Wilmington, DE -- (SBWIRE) -- 09/18/2013 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and JDS Uniphase Corporation (NASDAQ:JDSU).
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) a biopharmaceutical company that engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases is currently down (-0.85%) on 4,222,765 shares traded after Arena Pharmaceuticals announced to Present Clinical Data for BELVIQ CIV at the 49th Annual Meeting of the European Association for the Study of Diabetes. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is currently down (-47.73%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
JDS Uniphase Corporation (NASDAQ:JDSU) a company that provides communications test and measurement solutions, and optical products for telecommunications service providers, wireless operators, cable operators, network-equipment manufacturers, and enterprises worldwide is currently up (+0.46%) on 2,983,229 shares traded after JDSU announced to Showcase Latest Fiber Optic and 100G Technology at ECOC 2013. Hologic Inc. (NASDAQ:HOLX) is currently up (+62.74%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about JDS Uniphase Corporation (NASDAQ:JDSU)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)